Skip to content

Study of safety and efficacy of Endoscopic Ultrasonography with Jelly injection

Study of safety and efficacy of Endoscopic Ultrasonography with Jelly injection - USJ Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000028168
Enrollment
50
Registered
2017-07-14
Start date
2017-07-10
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal tract tumor and esophagogastric varix

Interventions

As a pretreatment for ultrasonic endoscope, inject up to 400 ml of OS-1 jelly in case of insufficient 5 minutes or 400 ml of water injection method.

Sponsors

Kanazawa University Hospital, Department of Gastroenterology
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Ultrasonic endoscopy with a probe method is planned with tumors of the esophagus, stomach, duodenum, small intestine, or large intestine, or with or suspected esophageal varices.

Exclusion criteria

Exclusion criteria: 1) Cases with occlusion or high stenosis in the gastrointestinal tract. 2) Patients with a history of aspiration pneumonia or suspected of deteriorating swallowing function. 3) A case in which it is judged that the risk of endoscopic examination complicates gastrointestinal diseases such as intestinal perforation and acute pancreatitis and the effectiveness is exceeded. 4) Cases in which respiratory circulation status is not stable due to respiratory diseases, cardiovascular diseases, etc. and it is judged that it is difficult to perform endoscopic examination safely. 5) Other cases that the person in charge judged inappropriate to participate in this exam.

Design outcomes

Primary

MeasureTime frame
Pre-treatment success rate of ultrasonic endoscopic examination

Secondary

MeasureTime frame
Serious adverse event

Countries

Japan

Contacts

Public ContactTakeshi Terashima

Kanazawa University Hospital Gastroenterology

hajimetakatori@gmail.com076-265-2235

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026